Literature DB >> 21910122

Engineering cocrystal solubility, stability, and pH(max) by micellar solubilization.

Neal Huang1, Naír Rodríguez-Hornedo.   

Abstract

Cocrystals offer great promise in enhancing drug aqueous solubilities, but face the challenge of conversion to a less soluble drug when in contact with solvent. This manuscript shows that differential solubilization of cocrystal components by micelles can impart thermodynamic stability to otherwise unstable cocrystals. The theoretical foundation for controlling cocrystal solubility and stability is presented by considering the contributions of micellar solubilization and ionization of cocrystal components. A surfactant critical stabilization concentration (CSC) and a solution pH (pH(max)) where cocrystal and drug are thermodynamically stable are shown to characterize cocrystal stability in micellar solutions. The solubility, CSC, and pH(max) of carbamazepine cocrystals in micellar solutions of sodium lauryl sulfate predicted by the models are in very good agreement with experimental measurements. The findings from this work demonstrate that cocrystal CSC and pH(max) can be tailored from the selection of coformer and solubilizing additives such as surfactants, thus providing an unprecedented level of control over cocrystal stability and solubility via solution phase chemistry.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21910122     DOI: 10.1002/jps.22725

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  14 in total

1.  Cocrystals Mitigate Negative Effects of High pH on Solubility and Dissolution of a Basic Drug.

Authors:  Yitian M Chen; Naír Rodríguez-Hornedo
Journal:  Cryst Growth Des       Date:  2018-02-14       Impact factor: 4.076

2.  Cocrystal Solubilization in Biorelevant Media and its Prediction from Drug Solubilization.

Authors:  Maya P Lipert; Lilly Roy; Scott L Childs; Naír Rodríguez-Hornedo
Journal:  J Pharm Sci       Date:  2015-09-21       Impact factor: 3.534

3.  Cocrystal Solubility Product Prediction Using an in combo Model and Simulations to Improve Design of Experiments.

Authors:  Alex Avdeef
Journal:  Pharm Res       Date:  2018-02-02       Impact factor: 4.200

4.  Understanding the Differences Between Cocrystal and Salt Aqueous Solubilities.

Authors:  Katie L Cavanagh; Chinmay Maheshwari; Naír Rodríguez-Hornedo
Journal:  J Pharm Sci       Date:  2017-10-31       Impact factor: 3.534

5.  Cocrystal Transition Points: Role of Cocrystal Solubility, Drug Solubility, and Solubilizing Agents.

Authors:  Maya P Lipert; Naír Rodríguez-Hornedo
Journal:  Mol Pharm       Date:  2015-08-28       Impact factor: 4.939

Review 6.  Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5.

Authors:  Gislaine Kuminek; Fengjuan Cao; Alanny Bahia de Oliveira da Rocha; Simone Gonçalves Cardoso; Naír Rodríguez-Hornedo
Journal:  Adv Drug Deliv Rev       Date:  2016-04-29       Impact factor: 15.470

7.  Investigation of the effect of hydroxypropyl methylcellulose on the phase transformation and release profiles of carbamazepine-nicotinamide cocrystal.

Authors:  Mingzhong Li; Shi Qiu; Yan Lu; Ke Wang; Xiaojun Lai; Mohammad Rehan
Journal:  Pharm Res       Date:  2014-03-04       Impact factor: 4.200

8.  Mechanistic Basis of Cocrystal Dissolution Advantage.

Authors:  Fengjuan Cao; Gordon L Amidon; Naír Rodríguez-Hornedo; Gregory E Amidon
Journal:  J Pharm Sci       Date:  2017-10-06       Impact factor: 3.534

9.  How cocrystals of weakly basic drugs and acidic coformers might modulate solubility and stability.

Authors:  G Kuminek; N Rodríguez-Hornedo; S Siedler; H V A Rocha; S L Cuffini; S G Cardoso
Journal:  Chem Commun (Camb)       Date:  2016-04-04       Impact factor: 6.222

Review 10.  Obtaining Cocrystals by Reaction Crystallization Method: Pharmaceutical Applications.

Authors:  Isabela Fanelli Barreto Biscaia; Samantha Nascimento Gomes; Larissa Sakis Bernardi; Paulo Renato Oliveira
Journal:  Pharmaceutics       Date:  2021-06-17       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.